Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer.
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) was widely accepted as a pivotal molecule in downregulating T-cell mediated immune responses. In this study we investigated the polymorphisms which would impact the CTLA-4 gene expression and function to assess the association with the risk of gastric cancer. 205 gastric cancer patients and 262 healthy controls were included in the case-control study. PCR and restriction fragment length polymorphism (RFLP) methods were performed to identify the +49A/G and promoter -1661A/G polymorphisms. The promoter -1772T/C polymorphism was detected by PCR amplification refractory mutation system (ARMS) technique. A significant difference was observed between case and control groups. The frequency of +49A/G polymorphism AG and -1661A/G polymorphism GG genotype were significantly higher in patients than in controls (OR = 2.15, OR = 1.88, respectively). No significant difference was found in the allelic frequency of -1772T/C polymorphism between cases and controls (P = 0.478). By the haplotype analysis, logistic regression showed the frequency of haplotype A (GAT) and D (AGT) in the case group revealed significant difference compared with in control group (OR = 2.00, P < 0.001; OR = 1.62, P = 0.043, respectively). Our findings implied the genetic variations within CTLA-4 gene would be a critical risk factor to the susceptibility of gastric cancer.
Hou
Ruiping
R
Department of Gastroenterology, Shandong Provincial Qianfoshan Hospital, Medical College, Shandong University, Shandong Province, China.
Cao
Bangwei
B
Chen
Zhongdong
Z
Li
Yong
Y
Ning
Tao
T
Li
Chunhui
C
Xu
Changqing
C
Chen
Ziping
Z
D015703:Antigens, CD / Q000235:genetics*; D060908:CTLA-4 Antigen; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D013274:Stomach Neoplasms / Q000235:genetics*
D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human
Genes Immun. 2001 May;2(3):145-52
11426323
J Immunol. 2000 Dec 1;165(11):6606-11
11086105
J Nutr. 2002 Nov;132(11 Suppl):3467S-3470S
12421872
Gastric Cancer. 2007;10(2):75-83
17577615
J Gastroenterol. 2009;44(4):239-48
19271114
Crit Rev Oncol Hematol. 2005 Jun;54(3):209-41
15890270
Mol Biol Rep. 2009 May;36(5):1001-5
18506597
J Oral Pathol Med. 2006 Jan;35(1):51-4
16393254
Hum Genet. 2002 Oct;111(4-5):452-5
12384790
Cell Oncol. 2005;27(5-6):281-92
16373962
Pediatr Pulmonol. 2007 Jun;42(6):542-7
17469155
Arthritis Rheum. 2004 Jan;50(1):328-9
14730632
Genes Immun. 2003 Mar;4(2):132-7
12618861
J Gastroenterol Hepatol. 2007 Dec;22(12):2283-7
18031393
Am J Hum Genet. 2001 Apr;68(4):978-89
11254454
Hepatology. 2000 Jan;31(1):49-53
10613727
J Exp Med. 2001 Sep 17;194(6):823-32
11560997
Mol Biol Rep. 2008 Dec;35(4):669-72
17874204
Science. 2006 Sep 29;313(5795):1972-5
16931720
Lancet Oncol. 2008 Mar;9(3):279-87
18308253
Expert Opin Biol Ther. 2009 Feb;9(2):231-41
19236253
Cancer Genet Cytogenet. 2006 Mar;165(2):114-20
16527605